Objective: To describe the epidemiological, diagnostic, therapeutic data and access outcomes of severe pulmonary embolism (PE) in the Cardiology Department of Kara Teaching Hospital. Materials and Methods: This was a cross-sectional study with retrospective data collection, carried out from January 2022 to June 2023 in the Cardiology Department of Kara Teaching Hospital. The study included the records of inpatients for severe PE diagnosed on the basis of clinical, ultrasound and angioscan findings. Results: During our study period, 42 patients were hospitalised for PE. Of these, 13 patients were treated for severe PE (30.9%). The mean age of these patients was 52.7 years, with a predominance of women (sex ratio M/F = 0.3). The average time to admission to cardiology was 4.7 ± 2.8 days. Thromboembolic risk factors were dominated by cancer (23.1%), pregnancy and childbirth (15.4%), HIV (15.4%) and prolonged immobilisation (15.4%). Ultrasound signs of acute pulmonary heart disease were present in all patients, with thrombus in the right cavities in three patients. Thoracic angioscan showed proximal involvement in 100% of cases and bilateral involvement in 50%. Streptokinase was the only thrombolytic agent used in 12 patients. Anticoagulant treatment in the acute phase was unfractionated heparin in 53.8% of cases and low molecular weight heparin in 46.2%, followed by oral anticoagulants (77.8%) and vitamin K antagonists (22.2%). The average hospital stay was 12.3 ± 5.2 days, with an in-hospital death rate of 30.8%. Conclusion: Severe PE remains a frequent medical emergency with a high mortality rate in our department, hence the need for better organisation of care services and improved technical facilities to improve patient prognosis.
References
[1]
Cohen, A. (1997) Embolie Pulmonaire. In: Baudry, G., Ed., Cardiologie et Pathologies Cardiovasculaieres, Editions Vernazobres-Grego, 775-816.
[2]
Torbicki, A., Perrier, A., Konstantinides, S., Agnelli, G., Galiè, N., Pruszczyk, P., et al. (2008) Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). European Heart Journal, 29, 2276-2315. https://doi.org/10.1093/eurheartj/ehn310
[3]
Raskob, G.E., Angchaisuksiri, P., Blanco, A.N., Buller, H., Gallus, A., Hunt, B.J., et al. (2014) Thrombosis: A Major Contributor to Global Disease Burden. Arteriosclerosis, Thrombosis, and Vascular Biology, 34, 2363-2371. https://doi.org/10.1161/atvbaha.114.304488
[4]
Wendelboe, A.M. and Raskob, G.E. (2016) Global Burden of Thrombosis: Epidemiologic Aspects. Circulation Research, 118, 1340-1347. https://doi.org/10.1161/circresaha.115.306841
[5]
Keller, K., Hobohm, L., Ebner, M., Kresoja, K., Münzel, T., Konstantinides, S.V., et al. (2019) Trends in Thrombolytic Treatment and Outcomes of Acute Pulmonary Embolism in Germany. European Heart Journal, 41, 522-529. https://doi.org/10.1093/eurheartj/ehz236
[6]
Olie, V., Chin, F. and De Peretti, C. (2013) La maladie veineuse thromboembolique: Patients hospitalisés et mortalité en France en 2010. Journal des Maladies Vasculaires, 38, 308. https://doi.org/10.1016/j.jmv.2013.07.040
[7]
Soya, E., N’Djessan, J.J., Traore, F., Kouame, S., Lawson, N., et al. (2019) Aspects épidemioclinique et thérapeutique de la maladie veineuse thromboembolique a l’Institut de Cardiologie d’Abidjan. Journal de la Recherche Scientifique de l’Université de Lomé, 21, 1-4.
[8]
Mbaye, A., Dioum, M., Ngaïdé, A., Diop, A., et al. (2016) Venous Thromboembolic Disease: Prevalence, Etiological Factors and Management in a Cardiology Department in Dakar, Senegal. Angeliology, 68, 47-53.
[9]
Pessinaba, S., Atti, Y.D.M., Baragou, S., Yayehd, K., Pio, M., Afassinou, Y.M., et al. (2019) La thrombolyse dans l’embolie pulmonaire à haut risque de mortalité: Expérience d’un service de cardiologie d’Afrique Subsaharienne. Annales de Cardiologie et d’Angéiologie, 68, 28-31. https://doi.org/10.1016/j.ancard.2018.08.026
[10]
Konstantinides, S.V., Meyer, G., Becattini, C., Bueno, H., Geersing, G., Harjola, V., et al. (2019) 2019 ESC Guidelines for the Diagnosis and Management of Acute Pulmonary Embolism Developed in Collaboration with the European Respiratory Society (ERs). European Respiratory Journal, 54, Article ID: 1901647. https://doi.org/10.1183/13993003.01647-2019
[11]
Konstantinides, S.V., Barco, S., Lankeit, M. and Meyer, G. (2016) Management of Pulmonary Embolism. Journal of the American College of Cardiology, 67, 976-990. https://doi.org/10.1016/j.jacc.2015.11.061
[12]
Philippot, Q., Roche, A., Goyard, C., Pastré, J., Planquette, B., Meyer, G., et al. (2018) Prise en charge de l’embolie pulmonaire grave en réanimation. Médecine Intensive Réanimation, 27, 443-451. https://doi.org/10.3166/rea-2018-0037
[13]
Lindblad, B., Eriksson, A. and Bergqvist, D. (1991) Autopsy-Verified Pulmonary Embolism in a Surgical Department: Analysis of the Period from 1951 to 1988. Journal of British Surgery, 78, 849-852. https://doi.org/10.1002/bjs.1800780725
[14]
Houenassi, M., Sacca-Vehounkpe, J., Tchabi, Y., Dossou-Yovo, R., Saizonou, F., Biaou, O., et al. (2013) Evaluation de la prise en charge de l’embolie pulmonaire dans un pays à faible niveau socio-économique: Cas du Bénin. Cardiologie Tropicale, 136, 1-5.
[15]
Konstantinides, S.V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., et al. (2014) 2014 ESC Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism. European Heart Journal, 35, 3033-3080. https://doi.org/10.1093/eurheartj/ehu283
[16]
Reißig, A., Haase, U., Schulze, E., Lehmann, T. and Kroegel, C. (2010) Prämortale Diagnostik und Therapie autoptisch bestätigter Lungenarterienembolien. DMW—Deutsche MedizinischeWochenschrift, 135, 1477-1483. https://doi.org/10.1055/s-0030-1262435
[17]
Pessinaba, S., Molba, Y.D., Baragou, S., Pio, M., Afassinou, Y., Kpélafia, M., et al. (2017) L’embolie pulmonaire au centre hospitalier universitaire Campus de Lomé (Togo): Étude rétrospective à propos de 51 cas. Pan African Medical Journal, 27, Article 129. https://doi.org/10.11604/pamj.2017.27.129.6855
[18]
Diall, I.B. (2011) Etiologie, clinique et évolution de l’embolie pulmonaire à propos de 30 cas à Bamako. Mali Medical, 26, 3-6.
[19]
Benhamou, Y., Delluc, A., Mauge, L., Fischer, A. and Sanchez, O. (2021) Quel bilan étiologique réaliser au décours d’une EP/TVP? Revue des Maladies Respiratoires, 38, e90-e98. https://doi.org/10.1016/j.rmr.2019.05.008
[20]
Codjo, L., Vovor, J.M., Hounkponou, M., Adjagbe, P., Sonou, A., Vehounkpe-Sacca, J., et al. (2018) Les thromboses veineuses profondes des membres thoraciques chez le sujet noir africain: À propos de 5 cas observés à L’USERC du CNHU-HKM de Cotonou. Pan African Medical Journal, 29, Article 113. https://doi.org/10.11604/pamj.2018.29.113.11999
[21]
Adam, A., Doune, N., Youssouf, M. and Abdassalam, M. (2021) Aspects épidémiologiques, cliniques, thérapeutiques et évolutifs de l’embolie pulmonaire au CHU la renaissance de N’Djamena (Tchad): Étude rétrospective. Annales Africaines de Médecine, 14, e4340-e4346.
[22]
Lorut, C. and Laaban, J.P. (1999) La valeur des signes cliniques et biologiques dans l’embolie pulmonaire. Revue des Maladies Respiratoires, 16, 885-893.
[23]
Doghmi, N., Cherradi, R., Madani, N., Abouqal, R., Zeggwaagh, A.A., Zekraoui, A. and Kerkeb, O. (1998) L’embolie pulmonaire grave (20 cas). Médecine du Maghreb, 71, 7-12.
[24]
Miniati, M., Monti, S., Pratali, L., Di Ricco, G., Marini, C., Formichi, B., et al. (2001) Value of Transthoracic Echocardiography in the Diagnosis of Pulmonary Embolism: Results of a Prospective Study in Unselected Patients. The American Journal of Medicine, 110, 528-535. https://doi.org/10.1016/s0002-9343(01)00693-3
[25]
Diehl, J.L. and Mercat, A. (1999) Gestion de l’embolie pulmonaire grave. Revue des Maladies Respiratoires, 16, 996-1006.
